Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays
EG Bouck, E Grinsztejn, M Mcnamara… - Research and Practice …, 2023 - Elsevier
Gender-affirming hormonal therapies are a critical component of the care of transgender
individuals. Transgender people are commonly prescribed estrogen or testosterone to …
individuals. Transgender people are commonly prescribed estrogen or testosterone to …
Pharmacologically mediated colon ischemia
DJ Hass, P Kozuch, LJ Brandt - … journal of the American College of …, 2007 - journals.lww.com
Colon ischemia (CI) is the most common form of ischemic injury of the gastrointestinal tract.
Determining the precise incidence of CI is a challenging task, because of its often brief, mild …
Determining the precise incidence of CI is a challenging task, because of its often brief, mild …
Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist
R Dittrich, H Binder, S Cupisti… - Experimental and …, 2005 - thieme-connect.com
In transsexual people, cross-sex hormone therapy is an important component of medical
treatment. In male-to-female transsexuals, feminizing effects should be achieved before …
treatment. In male-to-female transsexuals, feminizing effects should be achieved before …
Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression
G Krikun, F Schatz, R Taylor… - The Journal of …, 2005 - academic.oup.com
Controversy exists regarding the expression of specific steroid receptor proteins and mRNA
in human microvascular endometrial endothelial cells (HEECs). Thus, we studied steroid …
in human microvascular endometrial endothelial cells (HEECs). Thus, we studied steroid …
Isolated cortical vein thrombosis: case series
R Singh, WP Cope, Z Zhou, ME De Witt… - Journal of …, 2015 - thejns.org
OBJECT Isolated cortical vein thrombosis (ICVT) accounts for less than 1% of all cerebral
infarctions. ICVT may cause irreversible parenchymal damage, rendering early and accurate …
infarctions. ICVT may cause irreversible parenchymal damage, rendering early and accurate …
Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use
MY Zakharova, RM Meyer, KR Brandy… - Clinical and applied …, 2011 - journals.sagepub.com
The search for a safe and effective method of contraception has been ongoing for centuries.
During the last century, a variety of hormonal contraceptives, including combined hormonal …
During the last century, a variety of hormonal contraceptives, including combined hormonal …
Clinical practice guidelines for contraception by the French National College of Gynecologists and Obstetricians (CNGOF)
N Chabbert-Buffet, H Marret, A Agostini… - Journal of Gynecology …, 2019 - Elsevier
Abstract The French College of Obstetrics and Gynecology (CNGOF) has released its first
comprehensive recommendations for clinical practices in contraception, to provide …
comprehensive recommendations for clinical practices in contraception, to provide …
Therapy insight: guidelines for selection of contraception in women with rheumatic diseases
LR Sammaritano - Nature Clinical Practice Rheumatology, 2007 - nature.com
Use of contraceptives by women with rheumatic diseases, especially those with systemic
lupus erythematosus, has long been thought to carry risks, such as disease exacerbation …
lupus erythematosus, has long been thought to carry risks, such as disease exacerbation …
Oral contraception and thrombophilia
D Blickstein, I Blickstein - Current Opinion in Obstetrics and …, 2007 - journals.lww.com
Prospective users of oral contraception are potential candidates for screening/testing,
because a positive screen may substantially decrease the risk of a thrombotic event. At …
because a positive screen may substantially decrease the risk of a thrombotic event. At …
Contraception hormonale et risque vasculaire. RPC Contraception CNGOF
G Plu-Bureau, E Sabbagh, J Hugon-Rodin - … Obstétrique Fertilité & …, 2018 - Elsevier
Résumé Les événements vasculaires veineux ou artériels constituent le principal effet
délétère de l'utilisation des contraceptions hormonales combinées (CHC). Même si leur …
délétère de l'utilisation des contraceptions hormonales combinées (CHC). Même si leur …